A spokesperson for Medivation, which is helmed by David Hung, says that the best way to maximize shareholder value is to remain a standalone company. That said, the CEO is a consummate dealmaker. One last big buyout deal could prove appealing.
Maximizing shareholder value will be the greatest understatement of all time when people look back at the history of Peregrine Pharmaceuticals and how CEO Steve King has positioned shareholders for a reap of a reward to come.